96 related articles for article (PubMed ID: 24357745)
1. Epidermal growth factor receptor inhibitors: coming of age.
Mahipal A; Kothari N; Gupta S
Cancer Control; 2014 Jan; 21(1):74-9. PubMed ID: 24357745
[TBL] [Abstract][Full Text] [Related]
2. A review of cutaneous toxicities from targeted therapies in the treatment of colorectal cancers.
Urban C; Anadkat MJ
J Gastrointest Oncol; 2013 Sep; 4(3):319-27. PubMed ID: 23997943
[TBL] [Abstract][Full Text] [Related]
3. The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer.
Muhammad N; Usmani D; Tarique M; Naz H; Ashraf M; Raliya R; Tabrez S; Zughaibi TA; Alsaieedi A; Hakeem IJ; Suhail M
Cells; 2022 Jul; 11(14):. PubMed ID: 35883653
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
5. The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An
Zaryouh H; De Pauw I; Baysal H; Pauwels P; Peeters M; Vermorken JB; Lardon F; Wouters A
Front Oncol; 2021; 11():697967. PubMed ID: 34568028
[TBL] [Abstract][Full Text] [Related]
6. The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab
Baysal H; De Pauw I; Zaryouh H; Peeters M; Vermorken JB; Lardon F; De Waele J; Wouters A
Front Immunol; 2021; 12():737311. PubMed ID: 34557197
[TBL] [Abstract][Full Text] [Related]
7. Loss of CPAP causes sustained EGFR signaling and epithelial-mesenchymal transition in oral cancer.
Gudi RR; Janakiraman H; Howe PH; Palanisamy V; Vasu C
Oncotarget; 2021 Apr; 12(8):807-822. PubMed ID: 33889303
[TBL] [Abstract][Full Text] [Related]
8. Phase I Trial to Evaluate the Tolerance, Pharmacokinetics and Efficacy of the Broad-Spectrum ErbB Family Inhibitor Larotinib Mesylate in Patients With Advanced Solid Tumors.
Liu J; Zhang H; Zhu X; Chen H; Li X; Ding Y
Front Pharmacol; 2021; 12():636324. PubMed ID: 33679419
[No Abstract] [Full Text] [Related]
9. Piptides: New, Easily Accessible Chemotypes For Interactions With Biomolecules.
Arancillo M; Taechalertpaisarn J; Liang X; Burgess K
Angew Chem Int Ed Engl; 2021 Mar; 60(12):6653-6659. PubMed ID: 33319463
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Action of EGFR Tyrosine Kinase Receptor Incorporated in Extracellular Vesicles.
Zanetti-Domingues LC; Bonner SE; Martin-Fernandez ML; Huber V
Cells; 2020 Nov; 9(11):. PubMed ID: 33228060
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of oral cavity squamous cell carcinoma.
Hsu PJ; Yan K; Shi H; Izumchenko E; Agrawal N
Oral Oncol; 2020 Mar; 102():104552. PubMed ID: 31918173
[TBL] [Abstract][Full Text] [Related]
12. Rethink of EGFR in Cancer With Its Kinase Independent Function on Board.
Thomas R; Weihua Z
Front Oncol; 2019; 9():800. PubMed ID: 31508364
[TBL] [Abstract][Full Text] [Related]
13. PTEN Is Associated With Worse Local Control in Early Stage Supraglottic Laryngeal Cancer Treated With Radiotherapy.
Bruine de Bruin L; Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik MF; Langendijk JA; van der Wal JE; Schuuring E; van der Laan BFAM
Laryngoscope Investig Otolaryngol; 2019 Aug; 4(4):399-404. PubMed ID: 31453348
[TBL] [Abstract][Full Text] [Related]
14. Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors.
Thomas R; Srivastava S; Katreddy RR; Sobieski J; Weihua Z
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121829
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer.
Nami B; Maadi H; Wang Z
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30241301
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
De Pauw I; Lardon F; Van den Bossche J; Baysal H; Fransen E; Deschoolmeester V; Pauwels P; Peeters M; Vermorken JB; Wouters A
Mol Oncol; 2018 Jun; 12(6):830-854. PubMed ID: 29603584
[TBL] [Abstract][Full Text] [Related]
17. The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2.
Maadi H; Nami B; Tong J; Li G; Wang Z
BMC Cancer; 2018 Mar; 18(1):238. PubMed ID: 29490608
[TBL] [Abstract][Full Text] [Related]
18. Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.
Lenzo NP; Meyrick D; Turner JH
Diagnostics (Basel); 2018 Feb; 8(1):. PubMed ID: 29439481
[TBL] [Abstract][Full Text] [Related]
19. Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt.
Katreddy RR; Bollu LR; Su F; Xian N; Srivastava S; Thomas R; Dai Y; Wu B; Xu Y; Rea MA; Briggs JM; Zhang Q; Lu X; Huang G; Weihua Z
Oncogenesis; 2018 Jan; 7(1):5. PubMed ID: 29358623
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity.
Schaffrath J; Schmoll HJ; Voigt W; Müller LP; Müller-Tidow C; Mueller T
PLoS One; 2017; 12(6):e0178930. PubMed ID: 28591197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
